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Abstract
In our study we aimed to identify rapidly reacting gravity-responsive mechanisms in mammalian cells in order to
understand if and how altered gravity is translated into a cellular response. In a combination of experiments using
“functional weightlessness” provided by 2D-clinostats and real microgravity provided by several parabolic flight
campaigns and compared to in-flight-1g-controls, we identified rapid gravity-responsive reactions inside the cell
cycle regulatory machinery of human T lymphocytes. In response to 2D clinorotation, we detected an enhanced
expression of p21
Waf1/Cip1 protein within minutes, less cdc25C protein expression and enhanced Ser147-
phosphorylation of cyclinB1 after CD3/CD28 stimulation. Additionally, during 2D clinorotation, Tyr-15-
phosphorylation occurred later and was shorter than in the 1 g controls. In CD3/CD28-stimulated primary human T
cells, mRNA expression of the cell cycle arrest protein p21 increased 4.1-fold after 20s real microgravity in primary
CD4
+ T cells and 2.9-fold in Jurkat T cells, compared to 1 g in-flight controls after CD3/CD28 stimulation. The
histone acetyltransferase (HAT) inhibitor curcumin was able to abrogate microgravity-induced p21 mRNA
expression, whereas expression was enhanced by a histone deacetylase (HDAC) inhibitor. Therefore, we suppose
that cell cycle progression in human T lymphocytes requires Earth gravity and that the disturbed expression of cell
cycle regulatory proteins could contribute to the breakdown of the human immune system in space.
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Introduction
Gravity has been a constant force throughout evolution-
ary history on Earth. Thus, it is one of the fundamental
biological questions, if and how life on Earth requires
and responds to gravity at the functional cellular and
molecular level. In unicellular organisms, such as Para-
mecium and Loxodes, gravity can be perceived rapidly by
gravireceptors, which are gravi-sensitive ion channels in
the cell membrane or statocyst-like organelles [1]. In
mammalian cells, rapid gravi-responsive elements are
unknown.
The sensitivity of human cells exposed to reduced
gravity has already been suspected for cells of the
immune system since the first Apollo missions, where
more than half of the astronauts suffered from bacterial
or viral infections [2]. In one instance, an astronaut was
infected with an opportunistic pathogen, Pseudomonas
aeruginosa, which rarely causes disease in people with
functional immune systems. In crew members of Skylab
and Soyuz, a reduced reactivity of blood lymphoid cells
has also been observed [3,4]. Recent studies found a
subclinical re-activation of the varicella zoster virus
( V Z V )i na s t r o n a u t s[ 5 , 6 ] .T h i sv i r u sb e c o m e sl a t e n ti n
the nervous system after primary infection, but is fre-
quently reactivated in immune suppressed individuals,
such as after organ transplantation, or patients suffering
from cancer or AIDS. Because of the obvious and severe
effects on the human immune system, serious concerns
arose whether spaceflight-associated immune system
weakening ultimately precludes the expansion of human
presence beyond Earth’s orbit [7].
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important to ask if the molecular and cellular structure
of human life on Earth may require gravity for regular
function and survival, and if therefore gravity-dependent
mechanisms will keep us dependent on the gravity field
of Earth. Indeed, about one decade later, a pioneering
discovery from Cogoli et al. at the first Spacelab-Mis-
sions in the year 1983, where isolated human lympho-
cytes failed to proliferate after several days in
microgravity, provided the first strong evidence of cell
sensitivity to long-term reduced gravity exposure [8].
Follow-up experiments clearly verified the depression of
lymphocyte proliferation activation after mitogenic sti-
mulation in long-term microgravity [9].
During the last two decades, many studies evidenced
alterations in molecular mechanisms and signal trans-
duction processes in cells of the immune system as a
direct result of reduced gravity [10-30]. For instance, in
lymphocytes, microgravity affected protein kinase C
[10,11], influenced NF-kB and MAPK-signaling [13],
altered the expression of c-fos, c-myc and c-jun (sum-
marized in [14]), reduced the expression of IL-2 recep-
tor [21,22] and decreased the capacity for the
production of cytokines [23]. However, the underlying
molecular mechanisms are completely unknown. Given
the extremely complex nature of cellular signal trans-
duction networks in spatio-temporal dimensions, any
observed effect could be secondary, adaptive, driven by
negative or positive feedback-loops and thus far beyond
the initial and primary cellular response to altered grav-
ity. In order to perform the first step in elucidating the
cellular response to microgravity systematically, we
aimed to investigate if mammalian cells are rapidly
responding to reduced gravity and to discover the most
initial and earliest molecular reactions.
The only opportunity to perform experiments with liv-
ing mammalian cells in reduced gravity without leaving
our planet is onboard an aircraft performing parabolic
flight manoeuvres which is weightless when it is flying
on a Keplarian trajectory, described as an unpropelled
body in ideally frictionless space subjected to a centrally
symmetric gravitational field. In contrast to the logistic
limitations of the International Space Station ISS and
other space-based research platforms, parabolic flights
provide frequent and repeated access to microgravity
and therefore allow replication and modification of
experiments within a reasonable time frame, which are
not only characteristics, but rather requirements, of
modern biomedical research. In the search for rapid-
responsive molecular alterations in mammalian cells,
short-term-microgravity of 22s provided by parabolic
flight manoeuvres on board of the Airbus A300 is an
ideal instrument to elucidate these initial and primary
effects, widely without the influence or interference of
secondary signal cascades or feedback loops.
Because rapid reactions to reduced gravity in mamma-
lian cells have not been investigated so far, a technical
equipment and experimental platform to perform such
experiments in real microgravity was lacking. For this
reason, we recently developed an experimental system
which for the first time allows for large-scale cell culture
experiments with living mammalian cells on board of
the parabolic flight aircraft Airbus A300 ZERO-G [31].
Due to the fact that cells of the immune system are
obviously influenced by altered gravity [8-30], its gravi-
sensitive nature renders these cells an ideal biological
model in the search for primary gravisensitivity in mam-
malian cells.
Although access to microgravity provided by parabolic
flights is faster, more frequent and less complicated
than access to the microgravity of space, parabolic
flights are far from being a readily available day-to-day
method of gravitational research. Thus, scientists have
been innovative in order to find experimental
approaches to study the influence of gravity without
access to space or to special flight manoeuvres. For this
reason, so-called 2D clinostats complement the gravita-
tional research platforms by a solely-ground-based
device, which enable the rotation of a sample around
one axis perpendicular to the gravitational field [32].
The condition of weightlessness is characterized by the
lack of sedimentation and thus by a homogeneous dis-
tribution of particles. On ground, this situation can be
achieved by rotating a suspension of particles, which
will still fall, but will be also forced on circular paths
with decreasing radii through faster rotation of the sys-
tem. The clinostat rotation has to be fast enough to
achieve a situation where the rotated system no longer
perceives the rapidly turning gravity vector (compensa-
tion of the gravitational force) and thus experiences
“weightlessness” [33-37].
In a combination of experiments using “functional
weightlessness” provided by 2D clinorotation and real
microgravity provided by several parabolic flight cam-
paigns, we investigated rapid graviresponsiveness at the
molecular level in human T lymphocytes, the key player
of the specific immune response. Our aim was to iden-
tify a rapidly reacting gravity-responsive element in
mammalian cells.
Materials and Methods
General experimental procedure
1.) Functional weightlessness: The ground-based studies
in “functional weightlessness” were reviewed by the Eur-
opean Space Agency ESA (ESA-CORA-GBF-2005-005)
and performed under an ESA contract in collaboration
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test tube clinostat. Due to the present technical limita-
tion of the used DLR clinostat device, ultra-short clinor-
otation experiments (less th e n1m i ni n c u b a t i o nt i m e )
were not possible. Therefore, we focused on a time
frame which allows comparison of experiment results
with a follow-up study on board of a sounding rocket,
providing 5 min microgravity and which is scheduled
for the upcoming MASER-12 mission in February 2012
(based on ESA-AO-2004-010) 2.) Real microgravity: In
search of rapid-responsive molecular alterations in
mammalian cells, short-term-microgravity provided by
parabolic flight manoeuvres is an ideal instrument to
elucidate initial and primary effects, without the influ-
ence and interference of secondary signal cascades.
Parabolic flights provide 1 g, microgravity and hyper-
gravity conditions. The influence of hypergravity (1.8 g)
was tested separately on a labortatory centrifuge
(MUSIC, multi-sample centrifuge). For parabolic flight
experiments and especially for this study, we developed
and constructed a complete experimental system which
allows cell culture experiments with living mammalian
cells in microgravity on board the Airbus A300 ZERO-
G aircraft. Experiments in real microgravity were
reviewed by DLR and ESA and performed during five
parabolic flight campaigns provided by DLR and ESA.
The parabolic flight experiments were reproduced dur-
ing different independent flights and different indepen-
dent flight campaigns. Analysis of μgs a m p l e sa n d1g
in-flight-controls were performed using qRT-PCR.
Experiments in “functional weightlessness": Cell culture,
stimulation and sample preparation
Human Jurkat T-cells (ATCC TIB-152) were cultured in
RPMI-1640-medium (Sigma-Aldrich, Germany), supple-
mented with 10% FCS (Biochrom, Germany) and peni-
cillin/streptomycin (Sigma-Aldrich, Germany).
Stimulation was performed using 10 ng/ml soluble CD3
(BD Bioscience, Heidelberg, Germany) and 0.5 μg/ml
soluble CD28 antibodies (BD Bioscience, Heidelberg,
Germany) or alternatively by 10 ng/ml phorbolmyristyla-
cetate (PMA, Sigma-Aldrich, Germany) at a cell density
of 10
6 cells/ml under the conditions of clinorotation.
1g-control experiments have been performed inside the
clinostat, but without rotation. Cell suspensions were
carefully mixed with the activator solution (CD3/CD28
or PMA) or control solution (only medium) and filled in
the incubation tubes (sterile and sealed 1 ml pipettes,
Falcon) by an automatic pipette in order to avoid cell
shearing or damage. The time interval needed to stimu-
late cells prior to the start of altered gravity (mixing and
filling the incubation chamber) as well as the time
needed to harvest cells following altered gravity
(removal of the seal and transfer into ice-cold PBS) was
kept as short as possible and constant over all samples.
Under the chosen experimental conditions (60 rpm, pip-
ette diameter 4 mm), a maximal residual acceleration of
4×1 0
-3 g is achieved at the border of the pipette,
which decreases towards the center. The clinostat was
placed within an incubator thus providing constant tem-
perature conditions of 37°C during the experiments.
After clinorotation, the reaction was stopped immedi-
ately by the addition of ice-cold PBS (Sigma-Aldrich,
Germany). For preparation of total cell lysates, cells
were harvested in ice-cold PBS (Sigma-Aldrich, Ger-
many), centrifuged (300 g for 10 min), washed twice in
ice-cold PBS and stored as dry pellets at -80°C. At least
3 independent clinorotation experiments were
performed.
Sample analysis
For analysis of phosphorylation and expression of signal
molecules after clinorotation, cell lysates were analysed
by phospho-specific antibodies in immunoblots and
mRNA expression by quantitative RT-PCR. All antibo-
dies were from Cell Signaling Technology, Danvers,
MA. Quantitation was performed by Gene Profiler (Ver-
sion 3.56, Scananlytics Inc.) or Image J software
(National Institutes of Health, USA). Data were analysed
by one way ANOVA, followed by the Bonferroni test for
comparison of certain column pairs. p < 0.1 was consid-
ered to be significant, p < 0.01 as very significant and p
< 0.001 as extremely significant.
RNA isolation and cDNA synthesis for clinorotation
samples
After clinorotation of cells for 5, 10, and 15 min, Trizol
(life technologies, Darmstadt, Germany) was added to
stop the reaction and lyse the cells and RNA was iso-
lated according to the manufacturer’sp r o t o c o l .R N A
was subsequently purified using the RNeasy Mini kit
(Qiagen, Hilden, Germany) including the recommended
DNase digestion. RNA concentration and purity (260/
280 ratio) was measured in a Nanodrop spectrophot-
ometer (Thermo Scientific, Germany). 200 ng of RNA
were reverse transcribed using the SuperScript First-
Strand Synthesis System (Invitrogen, Karlsruhe, Ger-
many) and cDNA was used for TaqMan Gene Expres-
sion assays specific for p21 and beta-2-microglobulin
(Applied Biosystems/life technologies, Darmstadt, Ger-
many). Real time PCR analysis was performed on a light
cycler 480 (Roche Applied Science, Mannheim,
Germany).
Parabolic Flight experiments
The scientific community in Europe shares only one lar-
ger aircraft which is licensed for parabolic manoeuvres,
an Airbus A300 built in 1973, which is operated out of
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Cologne airport (Germany) by the company Novespace
and is flying up to 9 campaigns each year [31]. Experi-
ments have been performed during the 8th, 9th,10th
and 13th DLR Parabolic Flight Campaign and during
the 45th ESA Parabolic Flight Campaign inside the Air-
bus A300 ZERO-G, a specially-configured test aircraft
(NOVESPACE, Bordeaux, France), and under the stand-
ing orders of NOVESPACE (A300 ZERO-G Rules and
Guidelines RG-2001-1, RG-2008-1, RG-2008-2, RG-
2009-1 and RG-2009-02) and the CEV (Centre d’essai
en vol).
Development of in-flight-hardware
For the in-flight experiments on board the Airbus A300
ZERO-G, we developed an experimental system, which
allows cell culture tests with living mammalian cells in
microgravity. During the detailed design of the main
and secondary functional elements the basic design,
rules “simple” (e.g. use of a module system for the rack
design, only 15% of the required components are spe-
cially made), “clear” (e.g. principle of the liquid flow did
not lead to indefinable conditions) and “safe” (e.g.
redundant arrangement of parts absorbing forces, dou-
ble sealing of liquids) were met. Primary importance
was placed on realising the direct safety technique dur-
ing the development activity. The experimental structure
consists of three experiment racks (storage rack for cell
culture containers before the experiments, cooling rack
for storage of cell culture containers after the experi-
ments and a working rack for execution of the experi-
ments, see Figure 1). All modules have been developed
for performing experiments with living mammalian cells
during parabolic flights and allow storage of cell culture
compartments until the start of the experiment, injec-
tion of a fluid (activator) at the beginning of each para-
bola and automatic injection of a second fluid (fixation)
after 20s at the end of each parabola. Appropriate in-
flight controls have been obtained during the 1 g flight
phase directly before or after the parabola. The module
system can accommodate 60 cell culture containers for
each flight. Injection of all fluids operates automatically
and is pre-programmed, while exchange of cell culture
containers and supervision of the experiment is done by
the researchers during the parabolic flight. For a techni-
cal description of the in-flight-hardware, please refer to
the additional file 1 (short technical description of in-
flight-hardware).
Cell culture and preparation for parabolic flights
Human Jurkat T-cells (ATCC TIB-152) were cultured in
RPMI-1640-medium (Sigma-Aldrich, Germany), supple-
mented with 10% FCS (Biochrom, Germany) and anti-
biotics. PBMCs were isolated from the buffy coat
fraction from voluntary healthy donors (blood donor
service Zurich, Switzerland) using Ficoll Hypaque den-
sity gradient centrifugation. CD4
+ T-lymphocytes were
isolated from PBMCs using a commercially available
MACS-separation system (I M A G ,B DB i o s c i e n c e ) .F o r
each experiment, a separate blood donor was used. In-
flight μg and 1 g control experiments have been per-
formed in special in-flight cell culture bags (Nutrimix,
Braun, Melsungen, Germany) containing 3 × 10
7 cells in
15 ml medium per bag. In some flight experiments, 50
μM of the histone acetyltransferase (HAT) inhibitor cur-
cumin [38], 100 μM of the histone deacetylase (HDAC)
inhibitor valproic acid or 10 μMo ft h ep o l y - A D P -
ribose-polymerase-1 (PARP-1) inhibitor 5-aminoisoqui-
noline (AIQ) were added.
Cell and sample transports
Transport of cell culture bags with living cells in in-
flight-configuration and of fixed samples after the para-
bolic flight was carried out by military transport flights
(Beech 1900D, Swiss Air Force) from Zurich to
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Figure 1 Protein expression of p21 and p27 and
phosphorylation and protein expression of cdc2 in Jurkat T
cells after 1-15 min simulated weightlessness (μg) without
(con, a) and with stimulation with PMA at the onset of
simulated weightlessness (PMA, b). 1g-control experiments have
been performed inside the clinostat, but without rotation. 5
independent experiments were performed and pooled proteins
were analyzed. One representative beta-actin control is shown.
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flight day of the 13
th DLR Parabolic Flight Campaign.
During the 9
th DLR and 45
th ESA Parabolic Flight Cam-
paign in Bordeaux, they were transported to Bordeaux
by commercial flights inside the passenger cabin with
special permission. During the 10
th DLR Parabolic Flight
Campaign in Cologne, Germany, cell cultivation and
preparation could be performed on-site at the Biomedi-
cal Science Support Center (BC) of the German Aero-
space Center (DLR). After arrival at the flight location
the evening before the flight, cells were incubated over-
night at 37°C and all handled very carefully in order to
avoid any mechanical or temperature cell stress before
the flight. All steps of the entire cell preparation and
transport procedure have been tested extensively in
respect to cell viability and function beforehand (data
not shown). All procedures during the Parabolic Flight
Campaigns have been tested several times, are highly
standardized and follow an extensive and detailed stan-
dard protocol. During the campaign, all procedures have
been documented and double-checked.
Experimental procedures
In-flight μg and 1 g control experiments were performed
in special in-flight cell culture bags containing 3 × 10
7
cells in 15 ml medium per bag. During the onset of μg
or during 1 g (in-flight control experiments), 10 ng/ml
PMA or 10 ng/ml CD3 and 0.5 μg/ml CD28 or cell cul-
ture medium (non-stimulated cells) were added. After
20 s of μg or 1 g, cells were fixed by addition of 70%
ethanol (final concentration) and immediately cooled (4°
C) during the remaining flight. Experiments were per-
formed at least 3 times during independent flights and
separate flight days. After the flight, cells were trans-
ported to the laboratories, harvested and subjected to
analysis.
Parabolic flight manoeuvres
During a flight campaign, which normally consists of
three individual flights, 31 parabolas are flown on each
flight, with 93 parabolas in total. On each parabola,
there is a period of increased gravity (1.8 g) which lasts
for 20 seconds immediately prior to and following the
20 seconds period of reduced gravity (acceleration in x-,
y- and z-axis was below 2 × 10
-3g at all times during
the 0 g parabola). During the Parabolic Flight man-
oeuvre, the aircraft gradually pulls up its nose and starts
climbing at an angle of approximately 45 degrees. This
phase lasts for about 20 seconds, during which the air-
craft experiences an acceleration of around 1.8 g. The
engine thrust is then reduced to the minimum required
to compensate for air-drag, and the aircraft is then in a
free-fall condition, lasting approximately 20 seconds,
during which weightlessness is achieved. At the end of
this phase, the aircraft must pull out of the parabolic
arc, a manoeuvre which gives rise to another 20-seconds
period of 1.8 g on the aircraft, after which it returns to
normal level flight attitude. Special designated flight
areas were above the Atlantic Ocean and the Mediterra-
nean Sea. Three researchers executed the experiments
on board during each flight. Two loaded and unloaded
the cell containers in the working rack within 60s of the
1 g phase between each parabola. A third researcher
was in charge of operating the control unit and moni-
toring the subsystems. Each was trained to overtake any
other experimenter’sp o s i t i o ni nac a s eo fe m e r g e n c y .
All researchers on board were medically approved for
parabolic flights by the Parabolic Flight Medical Com-
mission, Caen, France.
RNA isolation and cDNA synthesis
360 μlo fT r i z o lw e r ea d d e dt oe a c hf r o z e nc e l lp e l l e t
and homogenized. After incubation for 5 min at room
temperature, the cell suspension was centrifuged for 10
min at 17000 rpm and 4°C. 5 μg of linear acrylamide
(Ambion/Applied Biosystems, Darmstadt, Germany) was
added to the supernatant and vortexed for 10 sec. 72 μl
of chloroform were added and the suspension was vor-
texed again before centrifugation at 17000 rpm for 5
min. The aqueous phase was mixed with 0.8 vol isopro-
panol and RNA was precipitated for 90 min at -20°C.
After precipitation of the RNA by centrifugation for 30
min at 17000 rpm and 4°C, the supernatant was
removed and the pellet was washed with 70% ethanol,
air dried, and re-dissolved in H2O. A DNaseI digestion
was performed (RNase free DNase set; Qiagen, Hilden,
Germany) according to manufacturer’s instruction. RNA
was purified by phenol-chloroform extraction and the
RNA was subsequently precipitated by addition of 1/10
vol 3 M Na-acetate (pH 4.8), 1 vol isopropanol and
incubation for 15 min at -80°C. The RNA was pelleted
by centrifugation at 17000 rpm for 15 min at 4°C and
washed twice with 70% ethanol. The RNA pellet was
resuspended in H2O and the concentration was mea-
sured photometrically. 1 μgo fR N Aw a sr e v e r s et r a n -
scribed using the RevertAid H Minus First Strand
cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany)
and random hexamer primer according to the manufac-
turer’s protocol.
Measurement of RNA quality
RNA quantity and purity was measured with a spectro-
photometer. Depending on the cell type, concentrations
varied between 10 and 544 ng/μl. RNA yields from pri-
mary T cells were usually low compared to RNA yields
from Jurkat T cells. RNA purity (260/280 ratio) ranged
between 1.7 and 2.0, sufficient for further analyses like
reverse transcription and real time PCR. Exemplary
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Bioanalyzer. RNA integrity numbers (RIN) between 2.4
and 3.2 were measured for the analyzed samples. We
added this informations in the material and methods
section.
Quantification by real time PCR and statistical analysis
1 μl of cDNA was used per real time PCR sample and
was added together with the primer for the gene of
interest and the reference gene respectively to the SYBR
Green PCR Master Mix reaction (Applied Biosystems
Darmstadt, Germany). Real time PCR was performed on
the 7500 Real Time PCR System (Applied Biosystems,
Darmstadt, Germany). The PCR primers used for the
study included: 5’-TGAGTGCTGTCTCCATGTTT-
GATG-3’ and 5’-TGCTCCCCACCTCTAAGTTGC-3’
specific for b2 microglobulin as a reference gene and 5’-
TGGAGACTCTCAGGGTCGAAAA-3’and 5’-GGAT-
TAGGGCTTCCTCTTGGAGA-3’for the gene of inter-
est p21. For each cDNA sample triplet reactions were
performed with p21 and b2 microglobulin specific pri-
mers and differences in gene expression levels were cal-
culated according to the Pfaffl method [39].
Subsequently, the Wilcoxon signed rank test was applied
to analyze the significance of the detected difference in
expression levels.
Results
Experiments in simulated weightlessness (2D
clinorotation)
Because long-term in vitro studies clearly revealed that
T cells lost their proliferative capacity in microgravity
[8,9], we first investigated key molecules of cell cycle
control in short-term simulated weightlessness provided
by 2D clinorotation of PMA-activated or non-activated
human Jurkat T lymphocytes (Figure 1, 2, 3). The first
set of experiments aimed to give a first impression on
possible rapid and early alterations in the cell cycle con-
trol machinery in T cells. Due to the construction prin-
ciple of the DLR-clinostat, reliable incubation times are
minutes long and therefore, technically we were not
able to perform clinorotation experiments with shorter
incubation times than 1 min.
Protein expression of p21 and p27 and phosphorylation
and protein expression of cdc2 in Jurkat T cells in
simulated weightlessness
In a first set of experiments, we investigated the protein
expression of the cell cycle inhibitory proteins p21
Waf1/
Cip1 and p27
Kip1 (Figure 1). We further investigated
Tyr15-phosphorylation of cdc2 (Figure 1), which is a
critical regulatory step in activating cdc2 during cell
cycle progression into mitosis [40]. After treatment of
Jurkat T cells with PMA, p21
Waf1/Cip1 protein expres-
sion was reduced 4.2-fold after 15 min in 1 g, but was
enhanced 1.6-fold after 15 min during clinorotation. p21
Waf1/Cip1. Protein expression during clinorotation was
4.6-fold higher compared to 1 g controls after 15 min
incubation with PMA. p27
Kip1 protein expression dur-
ing clinorotation was 1.4-fold higher compared to 1 g
controls after 15 min incubation without PMA stimula-
tion. Tyr15-phophorylation of cdc2 increased after incu-
bation with PMA in clinorotated as well as in 1 g
control samples. However, during clinorotation Tyr-15-
phosphorylation occurred later and was shorter than in
the 1 g controls. As a result of these clinostat experi-
ments, p21
Waf1/Cip1 protein expression is possibly
dependent on gravity conditions and therefore repre-
sents a candidate for early gravi-sensitive alterations in
T cells.
In addition to the protein expression levels (Figure 1),
mRNA transcription levels were analyzed for p21
Waf1/
Cip1 in Jurkat T cells by real time PCR using 2D clinoro-
tation for simulating 5, 10, and 15 min of weightlessness
(Figure 2). For all time points a 2-3 fold increase in p21
Waf1/Cip1 expression was observed in 1 g and simulated
μg conditions under the influence of PMA. Even in con-
trol experiments (con) where PMA was substituted by
medium the p21
Waf1/Cip1 expression level increased 2.4
- 2.7-fold. No difference between the μga n dt h e1g
group was detectable.
Protein expression and phosphorylation of cdc2, cdc25
and cyclinB1 in Jurkat T cells during simulated
weightlessness
Since cdc25 protein phosphatase is responsible for
dephosphorylating and activating cdc2 [41], we investi-
gated Ser216-phosphorylation of cdc25 (Figure 3).
When phosphorylated at Ser216, cdc25C binds to mem-
bers of the 14-3-3 family of proteins, sequestering
cdc25C in the cytoplasm, preventing premature mitosis
[42]. Phosphorylation of cyclin B1 is required for
cdc25C-dependent dephosphorylation of Tyr15 within
cdc2 and subsequent cdc2/cyclin B1 activation [43].
Therefore, we systematically investigated phosphoryla-
tion of cdc2 (Tyr15), cdc25 (Ser216) and cyclinB1
(Ser147) in Jurkat T cells after stimulation with PMA or
CD3/CD28 antibodies in simulated weightlessness pro-
vided by clinorotation compared with 1 g controls (Fig-
ure 3). In the next set of experiments, we detected less
cdc25C protein expression after 10 min stimulation with
CD3/CD28 in the presence of clinorotation compared to
1 g controls. Additionally, on average over all time
points, Ser147-phosphorylation of cyclinB1 was reduced
during clinorotation after PMA stimulation and
enhanced after CD3/CD28 stimulation. Other alterations
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could not be detected and, despite some slightly signifi-
cant gravity-dependent effects in cdc25C protein expres-
sion after 10 min, there were no substantial differences
in phosphorylation of cdc2 (Tyr15), cdc25 (Ser216) and
cyclinB1 (Ser147) in Jurkat T cells between clinorotated
and 1 g control samples in the time frame of 1-10 min.
In our experiments using “functional weightlessness”
provided by a 2D-clinostat, we found that p21
Waf1/Cip1
protein expression was distinctly higher in clinorotated
samples than in 1 g control samples after incubation
with PMA. Since detection of p21
Waf1/Cip1 protein in
samples from parabolic flights failed due to the technical
and logistical limitations of sample handling and proces-
sing during parabolic flight campaigns, we decided to
investigate p21 mRNA expression in real microgravity
provided during parabolic flights.
Experiments in real microgravity (parabolic flights)
As alterations of p21
Waf1/Cip1 and p27
Kip1 protein
expression and of Tyr15-phosphorylation of cdc2 (Fig-
ure 1) are probably a rapid response to simulated
weightlessness in Jurkat T cells, we further investigated
whether these effects could be detected and therefore
confirmed in real microgravity provided by parabolic
flights. During parabolic flight experiments, cells were
activated at the onset of μg (or during 1 g for in-flight
control experiments) by addition of PMA or CD3/CD28
(or of cell culture medium for baseline experiments)
and fixed 20s after the period of altered gravity.
Development of the experiment system for the Airbus
A300
The experiment hardware structure is demonstrated in
Figure 4 (please refer to the Figure 4 legend and to the
additional file 1). It consists of an incubator rack to
temporarily store the cell containers before the experi-
ment at 37°C, an experiment rack in which all active
aggregates are accommodated for the execution of the
experiment and where the living cells are handled dur-
ing altered gravity and a cooling rack to store tempora-
rily all cell containers after the injection of the stop/
fixation liquid at 4°C until landing.
The methodical approach to the development of an
experimental system which allows cell culture experi-
ments on board of an Airbus A300 during parabolic
flight manoeuvres was performed according to Pahl/
Beitz [44] with the four stages: task definition, concept
stage, design stage and final solution. The functional
engineering description or the overall function to be
fulfilled by the system setup was described as follows:
A test setup which enables three different cell lines to
be mixed, to a large extent homogeneously, with cer-
tain activator liquids at the start of the weightlessness
phase and a stopping liquid/fixative at end of the
weightlessness phase. Appropriate 1 g control
PMA con
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5,00
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Figure 2 mRNA expression of p21
Waf1/Cip1 in Jurkat T cells after 5, 10, and 15 min of simulated weightlessness (μg) by clinorotation.
PMA was added at the onset of weightlessness for cellular stimulation. 1 g control experiments were performed in the clinostat without
rotation. Control experiments (con) were performed for the time point 15 min with medium substituting the PMA. 3 independent experiments
were performed.
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Page 7 of 16p-cdc25C PMA CD3/CD28 con
p-cdc2 PMA CD3/CD28 con
cdc2 PMA CD3/CD28 con
cdc25C PMA con
p-cyclinB1 PMA CD3/CD28 con
cyclinB1 PMA CD3/CD28 con
CD3/CD28
Figure 3 Protein expression and phosphorylation of cdc2, cdc25 and cyclinB1 in Jurkat T cells at the onset (0 min) and after 1 min, 5
min and 10 min simulated weightlessness (μg) without (con) or with PMA (PMA) or CD3/CD28 soluble antibodies (CD3/CD28). 1g-
control experiments have been performed inside the clinostat, but without rotation. Three independent experiments were performed and
analysed separately by immunoblotting. Quantitation was performed by Gene Profiler software. The results are expressed as mean ± SEM. Data
were analysed by one way ANOVA, followed by Bonferroni test for comparison of certain column pairs. p < 0.1 = *, p < 0.01 = **, p < 0.001 =
***
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Figure 4 In-flight-experiment system during parabolic flights on board the Airbus A300 ZERO-G. a: Experiment hardware structure which
consists of an incubator rack to store the cell containers temporarily before the experiment at 37°C (1), an experiment rack, in which all active
aggregates are accommodated for the execution of the experiment and where the living cells are handled during altered gravity (2) and a
cooling rack to store temporarily all cell containers after the injection of the stop/fixation liquid at 4°C until landing (3). b. Structure of the
working rack, rear side. In range A (4°C) are three separate hose pumps, which pump one of the two possible stop liquids (e.g. ethanol or 4%
formaldehyde) into the cell containers. The pumps are activated and regulated by the control unit inside range C, which also carries all electrical
connections and fuse elements. All liquids are sucked under exclusion of air. Inside range B (37°C) are three bags with activator liquids,
connected to three separate hose pumps, which pump the activator solution into the cell container upon activation of the individual
experiment. c. Structure of the working rack, front side. Range D is the actual working space with three cell containers in parallel, which are
connected to the activator and fixation liquid bag. Range D is also waterproof and the door position is controlled by a safety switch (sensor).
Activation of the experiment is only possible when the front door is closed. d. Double-wall liquid-proof cell container. A maximum of 60
container can be accommodated during one flight. 1 = plastic container, 2 = air valve, 3 = internal sterile cell culture bag (Nutrimix 0.25l), 4 =
connector 1 (activator liquid), 5 = connector 2 (stop/fixation liquid), 6 = connector 3 (filling port for cells, performed preflight), 7 = plastic flange.
e. Fluid loop diagram for one cell container. The entire experiment system has three identical fluid loops.
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Page 9 of 16experiments had to be executed on board. A main
requirement was the fulfilment of all safety require-
ments. Primarily, it must be ensured that liquids never
leak from the test setup during the parabolic flights,
which could cause a hazard to the flight personnel as
well as damage to the electric systems of the aircraft.
Thus, all equipment in contact with liquids must be
designed with double liquid-proof walls. A further
requirement was the temperature of the cells and acti-
vator liquids (37°C) and the temperature of the stop
liquid/fixative (4°C). Further points included in the
functional engineering description and task definition
stage were a.) enable fast and easy equipping with
liquids, b.) realisation of the direct safety stage, i.e.
leak-proof under the conditions in the aircraft, c.) clear
functional sequences, d.) good miscibility of the liquids
during the experiment in the cell culture bag, e.) fill
under exclusion of air, f.) to a large extent transparent
construction for observation whether air inclusions
exist, g.) low weight (mass), h.) small space require-
ment and i.) to fulfil all applicable rules and regula-
tions by the aircraft operator. In the conceptual design
stage, the overall function is structured into its sub-
functions and their links and efficacy principles were
then assigned to the sub-functions. Conventional,
intuitive and discursive solution finding methods were
used to draw suitable action principles. It was of pri-
mary importance that the high safety requirements be
fulfilled with all the selected efficacy principles.
Enhanced p21
Waf1/Cip1 mRNA expression in real
microgravity
Jurkat T cells and primary T cells were exposed to 20s
of microgravity during parabolic flights and analysed
for their differential gene expression of p21
Waf1/Cip1
(cyclin-dependent kinase inhibitor 1) which functions
as a regulator of cell cycle progression at the G1 phase
by directly inhibiting the activity of cyclinE/CDK2 and
cyclinD/CDK4 complexes (Figure 5). Three different
conditions were tested: 1.) medium was injected as a
control solution to identify effects of microgravity on
gene expression without stimulation (con), 2.) PMA
was used to activate directly the signal transduction
enzyme protein kinase C (PKC) and 3.) CD3/CD28
antibodies were applied to stimulate the cells via their
T cell receptor (TCR) and CD28 receptor (CD3/
CD28). Comparison of 1 g and μgs h o w e dt h a te v e n
for non-stimulated conditions, an increased p21
Waf1/
Cip1 gene expression (1.9 fold in Jurkat T cells and 2.3
in primary CD4
+ T cells, Figure 5ab) is detectable. In
CD3/CD28-stimulated Jurkat T cells and primary CD4
+ T cells, increased p21
Waf1/Cip1 gene expression was
upregulated 2.9-fold and 4.1-fold, respectively (Figure
5ab).
Histone acetylation-dependent p21
Waf1/Cip1 mRNA
expression in real microgravity
Because histone acetylation is described as one of the
regulators of p21
Waf1/Cip1 gene expression, we investi-
gated the effect of the histone acetyl-transferase (HAT)
inhibitor curcumin and the histone deacetylase (HDAC)
inhibitor valproic acid on microgravity-triggered p21
Waf1/Cip1 gene expression. We found that curcumin
abrogated the microgravity-induced p21
Waf1/Cip1 gene
expression, whereas valproic acid had the opposite effect
(Figure 5c). Additionally, the poly-ADP-ribose-polymer-
ase-1-inhibitor 5-aminoisoquinoline (AIQ) had no sig-
nificant effect on microgravity-induced p21
Waf1/Cip1
gene expression (Figure 5c). The use of genetically mod-
ified organisms or siRNA knockdown methods was pro-
hibited on board the Airbus A300 ZERO G and
therefore not possible (remark: the use of genetically
modified organisms is now possible after approval by
the French authorities).
Enhanced Tyr15-phosphorylation of cdc2 in real
microgravity
We could detect an enhanced Tyr15-phosphorylation of
cdc2 in PMA- and in CD3/CD28 stimulated Jurkat T
cells after 20s real microgravity, but not in non-stimu-
lated cells (Figure 5d). In microgravity, Tyr15-phosphor-
ylation of cdc2 after addition of PMA or CD3/CD28
was enhanced 1.44-fold or 1.35-fold, respectively, com-
pared to 1 g-in-flight-controls. Without stimulation,
Tyr15-phosphorylation of cdc2 was reduced 1.85-fold in
microgravity. Due to the technical and logistical limita-
tions of sample fixation and sample transport after a
parabolic flight, we were not able to detect p21
Waf1/Cip1
or p27
Kip1 protein in the flown samples by commer-
cially available antibodies.
In conclusion, we detected an enhanced expression of
p21
Waf1/Cip1 p r o t e i nw i t h i nm i n u t es of clinorotation
and an enhanced expression of p21
Waf1/Cip1 mRNA
within 20s of real microgravity, which could be abro-
gated by the HDAC inhibitor curcumin. Additonally, we
found an enhanced Tyr15-phosphorylation of cdc2 in
real microgravity. Therefore, we identified a rapid effect
of microgravity on the expression of a cell cycle regula-
tory gene in mammalian cells.
Discussion
Because gravity is present everywhere on Earth, scien-
tists and engineers have to be highly innovative in order
to find experimental approaches for studying the influ-
ence of gravity without leaving our planet. Utilization of
microgravity research platforms requires long-term
planning, technical innovations and extraordinary safety
efforts. Beyond the technical and logistical challenges,
results arising from such experiments frequently do not
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posals are often required, long waiting times are preva-
lent, and administrative and logistical challenges have to
be solved. Therefore, it is difficult to perform biomedical
research using microgravity platforms with the same rig-
orous logical thoroughness as on ground, and gaps in
the logical chain of reasoning often cannot be filled due
to limitation of research platforms, both in terms of
availability and in terms of the technical and logistic
framework.
The validity of the 2D fast-rotating clinostat has been
shown through a direct comparison of data from simu-
lation experiments with that from space experiments
using T-lymphocytes [9,21,45-47]. In general, results
from comparative studies obtained so far (space and
fast-rotating 2D clinostat experiments) are similar,
though the response in real microgravity appears to be
more pronounced and/or faster [32]. Experiments on
board parabolic flights using the Airbus A300 aircraft
are an optimal research platform to investigate initial
alterations of cellular mechanisms in microgravity with-
out the influence or interference of secondary signal cas-
cades or feedback loops. For this reason, we developed a
new experimental system, which for the first time allows
for large-scale cell culture experiments with living mam-
malian cells onboard the parabolic flight aircraft Airbus
A300 ZERO-G. During parabolic flight manoeuvres, a
repeated state of “weightlessness” is achieved. However,
true weightlessness (= zero gravity) does not exist due
to the presence of masses in our universe. Even at an
Jurkat T cells
Jurkat T cells
+ CU/VP/AIQ
Primary CD4+ T cells a
c
b
d
Figure 5 Expression of p21
Waf1/Cip1 mRNA in real microgravity provided by parabolic flights in non-stimulated (con) or stimulated
(PMA or CD3/CD28) Jurkat T cells or primary CD4
+ T cells. p21
Waf1/Cip1 mRNA expression is demonstrated as ratio between expression in
microgravity (μg) and 1 g in fig.5ab. In fig. 5c, p21
Waf1/Cip1 mRNA expression is demonstrated as the ratio between expression in microgravity
(μg) with a pharmacological inhibitor (VP, CU or AIQ) and without. Three independent experiments were analysed. VP = valproic acid, CU =
curcumin, AIQ = 5-aminoisoquinoline. Results are expressed as mean ± SEM. Data were analysed by Wilcoxon test. p < 0.1 = *, p < 0.05 = **. In
fig 5d, phosphorylation of cdc2 in Jurkat T cells after 20s real microgravity provided by parabolic flight manouvres in non-stimulated (con) or
stimulated (PMA or CD3/CD28) cells is shown. PMA or CD3/CD28 was added at the onset of altered gravity. Loading control: corresponding gel
stained by Coomassie after blotting. Five independent experiments during different flight days were performed and pooled protein was
analysed.
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Page 11 of 16altitude of e.g. 350 km, which corresponds to the orbital
position of the ISS, the level of gravity is still 9.04 ms
-2
compared to 9.81 ms
-2 at the Earth’s surface. But if the
gravitational and centrifugal forces are equal in amount,
but opposite in their vectors, free-fall ("weightlessness”)
condition is achieved for a spacecraft. This situation is
named „microgravity” because of the residual accelera-
tion in the range of 10
-4 -1 0
-6 g. Whereas sedimenta-
tion, hydrostatic pressure and convection are linearly
proportional to gravity, diffusion still persists in micro-
gravity. Thus, microgravity might act directly or indir-
ectly on a biological system [33,48]. Indirect effects of
microgravity on the cellular surrounding have to be con-
sidered, such as an optimal distribution of food particles
due to the lack of sedimentation. It is important to note
that, according to current knowledge, results obtained
under hypergravity and 1 g conditions cannot simply be
extrapolated to microgravity, as revealed by the exis-
tence of thresholds for perception of the stimulus grav-
ity. It is obvious that in many cases the total lack of the
stimulus (gravity) is a total new sensation [32].
As a result of the experimental conditions using the
2D clinostat or the aircraft, cells are subjected to irregu-
lar stress by cell preparation and handling and - in the
case of parabolic flight - by the flight experiment itself.
Thus, it is important that the experimental conditions,
despite an internal 1 g control always being present, do
not alter the cellular and molecular “baseline” beyond
an absolute minimum. Therefore, the response to exo-
genous activators such as PMA (protein kinase C activa-
tion) and CD3/CD28 (T cell receptor activation) in 1 g
control conditions of the experiment should be nearly
t h es a m ea sd u r i n g“regular” laboratory conditions. In
our study, we detected alterations in the phosphoryla-
tion of cdc2, cdc25C and cyclinB1 in response to PMA
and CD3/CD28 treatment (Figure 3) and a upregulation
of the cell cycle control protein p21
Waf1/Cip1 (Figure 1).
Also during the parabolic flight experiments, cells were
responsive to the activator during the 1 g control phase
( F i g u r e5 c ) .T h e r e f o r e ,w ec o n c l u d et h a tt h ep e r f o r m e d
clinostat and parabolic flight experiments fulfil the con-
dition of sufficient cell responsiveness to exogenous
stimuli.
The clinorotation experiments analyzing the p21
Waf1/
Cip1 protein expression level clearly shows opposed
effects for μg and 1 g (Figure 1). While in control and
PMA stimulated cells the amount of protein is increas-
ing over time (1 - 15 min) in simulated weightlessness,
it is clearly decreasing in 1 g conditions with progres-
sing time (1 - 15 min). The absence of a comparable
result in the clinorotation p21
Waf1/Cip1 mRNA expres-
sion experiment (Figure 2)i m p l i e st h a ti ne v e ns h o r t
time clinostat analyses of 5 to 15 min, a translational
rather than a transcriptional effect is prevailing.
However, experiments performed in real microgravity
during parabolic flights show that also effects on p21
Waf1/Cip1 mRNA transcription are detectable (Figure 5).
After 20 s of μg, gene expression levels were increased
about 2-fold in control reactions whereas the application
of PMA decreased p21
Waf1/Cip1 expression levels to 1 -
1.6-fold. A time series up to several minutes to compare
the development of gene expression with the clinostat
results was impossible because the μg time during para-
bolic flights is restricted to 20 s per experiment.
2D clinorotation is a well established method to simu-
late weightlessness on Earth [9,21,32,46-52] and its
validity has been demonstrated through comparison
with data from space experiments, e.g. in the case of T
lymphocytes [9,46-51]. However, in our case it is diffi-
cult to compare time-points from the different research
platforms directly due to technical restrictions. Within
the clinostat, activator solutions (such as CD3/CD28 or
PMA) have to be added directly before starting clinoro-
tation (in contrast to the technical equipment in the
flight hardware allowing the addition of activator solu-
tions directly during the onset of microgravity). There-
fore, the 0 min time points represent different
conditions: in the clinostat experiments (Figure 3), onset
of different gravity conditions (clinorotation vs. 1 g con-
trol) and not the time point of addition of PMA or
CD3/CD28 as in the flight experiment. Thus, PMA- and
CD3/CD28-induced signalling was already active at the
0 min time point in the clinostat and the measured
values at 0 min differs between the non-treated and the
treated groups. Due to this technical limitation, reliable
incubation times using the DLR-clinostat are within a
time frame of minutes and therefore much longer than
the 22s microgravity provided by the Airbus A300.
Thus, it is not possible to validate both research plat-
forms reciprocally, however - as 2D clinorotation is an
established simulation method [9,21,32,46-52] - the data
from both platforms can be discussed in conjunction,
but with caution and an awareness of their limitations.
The 20s of the parabolic flight experiments can not be
compared directly and kinetically with the 1-10 min
time point of the 2D clinostat experiments. For this rea-
son, we only compared μg versus 1 g within the respec-
tive experimental platform in order to obtain general
information about the gravi-sensitivity of certain mole-
cular reactions. However, the observed gravity-depen-
dent p21
Waf1/Cip1 regulation could be demonstrated in
both platforms.
Several investigations provide evidence of alterations
in signal transduction. In lymphocytes, microgravity
affected the protein kinase C [10,11], but not the patch-
ing and capping of conA-binding membrane proteins
[12], influenced NF-kB and MAPK-signaling [13] and
the expression of the early oncogenes c-fos, c-myc and c-
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Page 12 of 16jun (summarized in [14]). Other studies demonstrated
pro- and antiapoptotic effects of altered gravity in
human mononuclear cells [15], human ML-1 thyroid-
carcinoma cells [16], and astrocytes [17] and influences
on fas, p53, bax and bcl-2 were described [16,18,20]. A
reduced expression of IL-2 receptor [21,22] and a
decreased capacity for the production of cytokines [23]
were prominent effects of microgravity on T lympho-
cytes. In microgravity, monocytes lost their capability of
secreting IL-1 [24] and expressing IL-2-receptor [25]
and demonstrated significant changes in gene induction
associated with differentiation of monocytes into macro-
phages [26], a reduction of phagocytosis and oxidative
burst- and degranulation-capacity [27] and massive
alterations in the cytoskeleton [28], which in turn influ-
ences obvious motility [29]. It seems that not all cell
types of the immune system are sensitive to reduced
gravity: Extensive studies with natural killer cells in
simulated weightlessness and in real microgravity on
board the ISS revealed that neither cytotoxic effects nor
interferon production is altered in microgravity [30].
In our study we found that p21
Waf1/Cip1 mRNA
expression is enhanced in microgravity compared to 1 g
in CD3/CD28-activated Jurkat T cells and in primary
CD4
+ - T cells, but also in non-stimulated Jurkat T
cells. p21
Waf1/Cip1 i so n eo ft h ep 5 3t a r g e tm o l e c u l e s ,
inhibiting the activity of the cyclinB1/Cdc2 complex
[53], leading to a cell cycle arrest. The cell cycle arrest
can be induced experimentally by stimulating cells with
PMA [54]. PMA activates the protein kinase C, which
leads to a p21
Waf1/Cip1 upregulation [55,56], a decrease
of cyclinB1/cdc2 concentration [57] and subsequent
inhibition of the cell cycle at the G1/S and G2/M phase.
We further discovered that the histone acetyl-transferase
(HAT) inhibitor curcumin abrogated the microgravity-
induced overexpression of p21
Waf1/Cip1 mRNA, whereas
the histone deacetylase (HDAC) inhibitor valproic acid
enhanced p21
Waf1/Cip1 mRNA expression in micrograv-
ity. Interestingly, a recent study found epigenetic altera-
tions in cells exposed to simulated weightlessness and
also revealed a decreased expression of a histone deace-
tylase [58]. Other studies in long-term simulated weight-
lessness found intact T cell receptor signalling [49], but
alterations in cell cycle [50] control and upregulation of
p21
Waf1/Cip1 [51,52]. The p21
Waf/cip1 gene consists of
492 bp coding sequence emerging from a pre-mRNA of
maximally 8682 bp, small enough to function as a regu-
lator for cellular responses viad i f f e r e n t i a lg e n ee x p r e s -
sion. In human fibroblasts p21
Waf/cip1 expression levels
were increased 8-9 fold only after 30 min of microbeam
irradiation [59]. Here we show that gene expression
levels are altered even within tens of seconds. The
observed overexpression of p21
Waf/cip1 is conceivable by
rapid transcriptional induction considering the high
elongation speed of the RNA polymerase II. While mea-
sured elongation velocities reached up to 4.3 kb per min
[60], theoretically velocities even above 50 kb per min-
ute have been calculated [61] allowing a significant
increase in gene expression after 20s only.
The p21 gene is under the transcriptional control of
p53, suggesting that p21 might promote p53-dependent
cell cycle arrest or apoptosis [62]. We recently found
that p53 was phosphorylated rapidly in proliferating
human U937 cells during the microgravity phase of
parabolic flights [63]. Therefore, a role of p53 in micro-
gravity-dependent p21-expression can be assumed.
However, the rapid appearance of p21 RNA during 20
seconds of microgravity suggests a more direct effect of
altered gravity on p21 transcriptional regulation.
During human space flight, human cells are exposed
to microgravity and the radiation of space. p21
Waf1/Cip1
is a master effector of multiple anti-proliferative path-
ways [64] reacting e.g. on cellular DNA damage induced
by radiation [59,65]. Because p21 is obviously essential
for cell cycle arrest induction after radiation [62,66] and
radiation increased the expression of p21 [66], a key
role of p21 in radiation-induced cell cycle arrest in the
cellular response to DNA damage [67] has been sug-
gested. On the other side, it has been shown that ioniz-
ing radiation induces ubiquitin-dependent degradation
of p21Cip1 and therefore contributes to the survival of
neoplastic cells after ionizing radiation [67]. We suggest
that microgravity-induced transcriptional induction of
p21 represents a possible mechanism of synergistic
effects between microgravity and space radiation which
could finally contribute in cell cycle arrest, enabling
DNA repair.
Interestingly, DNA microarray analysis from rat mus-
cle RNA during the NASA STS-90 Neurolab spaceflight
mission revealed an inhibition of genes for cell prolifera-
tion compared to 1 g ground controls, supporting also
an in vivo down-regulating effect of space flight on cell
cycle progression [68]. Recent studies investigated the
effect of systemic stress induced by microgravity or
space flight and their mediators on the human immune
system [69,70]. Our results suggest that microgravity is
perceived by cells of the human immune system as a
stress signal which is then translated into rapid intracel-
lular responses. Identifying gravi-sensitive signal trans-
duction pathways in cells of the immune system will
help to find appropriate targets for therapeutic interven-
tion or preventive countermeasures related to the
immune system of astronauts during long-term space
missions. As a result of our study, we suppose that cell
cycle progression in human T lymphocytes requires
Earth gravity. Additionally, we found that microgravity-
induced overexpression of p21
Waf1/Cip1 mRNA was abro-
gated by the histone acetyltransferase inhibitor
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cuma longa L.), a member of the ginger family (Zingi-
beraceae), an approved food additive. Rapid induction of
cell cycle arrest signaling in microgravity could repre-
sent a protective cellular reaction to enable DNA repair,
energy saving and recovery after gravitational stress.
Additional material
Additional file 1: Short technical description of in-flight-hardware.A
short summary of the most important technical parameters of the in-
flight-hardware such as rack configuration, weight, dimensions and
power supply.
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